1. Home
  2. For Patients
  3. Learn About FDA Patient Engagement
  4. FDA Patient Listening Sessions
  5. Planning an FDA Patient-Led Listening Session
  1. FDA Patient Listening Sessions

Planning an FDA Patient-Led Listening Session

5 PHOTO Online Listening 226

 

The FDA Public Engagement Staff leads the Patient Listening Session program and will coordinate internal review of Patient Listening Session requests on a quarterly schedule as follows: 

  • Requests submitted January 1 – March 31 will be reviewed starting April 1 
  • Requests submitted April 1 – June 30 will be reviewed starting July 1 
  • Requests submitted July 1 – September 30 will be reviewed starting Oct 1 
  • Requests submitted Oct 1 – December 31 will be reviewed starting January 1   

Planning for an FDA patient-led listening session typically takes four to six months. After the Patient Listening Session has been scheduled, the patient(s)/organization who requested the listening session should:

  1. Work with other patient organizations/groups within the same disease area/health condition to collaborate on the listening session.
  2. Have approximately three total meetings with FDA:
    • Meeting 1 (an introductory meeting): discuss logistics of planning a listening session with the FDA.
    • Meeting 2 (planning meeting): review the agenda and meeting materials with the FDA.
    • Meeting 3 (preparation meeting): practice/dry run of the listening session in preparation for the listening session.
  3. Send final agenda and meeting materials to FDA Public Engagement Staff at least two weeks prior to the listening session.
  4. Share, in advance, any financial interests that patients, caregivers, clinicians, or organizations participating may have related to this Patient Listening Session topic.
  5. Conduct the FDA patient-led listening session over Teams.

Learn more about Patient Listening Sessions:

Patient Listening Sessions - Home

Back to Top